Company Filing History:
Years Active: 2000
Title: Abraham Yacobi: Innovator in Pharmaceutical Formulations
Introduction
Abraham Yacobi is a notable inventor based in New City, NY (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of sustained release formulations. His work focuses on improving the delivery and effectiveness of anti-epileptic medications.
Latest Patents
Abraham Yacobi holds a patent for a sustained release formulation of carbamazepine. This invention provides a pharmaceutical preparation in tablet form, where the active ingredient is an anti-epileptic medication. The formulation consists of carbamazepine particles coated with a single hydrophobic layer, designed to be in a disintegrating tablet form. This innovative approach enhances the therapeutic efficacy of carbamazepine, making it a valuable option for patients requiring long-term treatment.
Career Highlights
Abraham Yacobi is associated with Taro Pharmaceutical Industries Limited, where he applies his expertise in pharmaceutical formulations. His work at Taro has contributed to the advancement of medication delivery systems, particularly for patients with epilepsy.
Collaborations
Abraham has collaborated with talented coworkers such as Daniela Licht and Marina Zholkoysky. Their combined efforts in research and development have led to significant advancements in pharmaceutical technologies.
Conclusion
Abraham Yacobi's innovative work in sustained release formulations exemplifies the importance of research in improving patient care. His contributions to the pharmaceutical industry continue to make a positive impact on the lives of those affected by epilepsy.